We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
76
Centene
CNC
$31.3B
$71.8M 0.33%
1,141,990
-1,185,873
-51% -$64.3M
ADP icon
77
Automatic Data Processing
ADP
$100B
$69.5M 0.32%
407,897
-657
-0.2% -$109K
EFA icon
78
iShares MSCI EAFE ETF
EFA
$76.4B
$68.8M 0.31%
990,202
-32,587
-3% -$2.2M
MO icon
79
Altria Group
MO
$122B
$68.7M 0.31%
1,376,049
+956,486
+228% +$45.1M
LLY icon
80
Eli Lilly
LLY
$1.07T
$68.2M 0.31%
519,073
-298,422
-37% -$34.6M
DG icon
81
Dollar General
DG
$25.9B
$67.2M 0.31%
430,667
-155,078
-26% -$24.6M
SBUX icon
82
Starbucks
SBUX
$118B
$67M 0.31%
762,586
-935,175
-55% -$79.7M
AES icon
83
AES
AES
$10.6B
$66.9M 0.31%
3,363,003
-399,433
-11% -$7.15M
RTN
84
DELISTED
Raytheon Company
RTN
$66.5M 0.3%
302,826
+4,887
+2% +$1.03M
NEE icon
85
NextEra Energy
NEE
$187B
$66.4M 0.3%
1,097,132
-30,544
-3% -$1.78M
VIG icon
86
Vanguard Dividend Appreciation ETF
VIG
$111B
$66.1M 0.3%
530,112
+8,063
+2% +$975K
ITW icon
87
Illinois Tool Works
ITW
$81.4B
$65.2M 0.3%
363,163
-16,334
-4% -$2.77M
ALXN
88
DELISTED
Alexion Pharmaceuticals
ALXN
$65M 0.3%
601,053
+581,631
+2,995% +$62.2M
MMM icon
89
3M
MMM
$89B
$65M 0.3%
440,371
-216,150
-33% -$30.3M
IWM icon
90
iShares Russell 2000 ETF
IWM
$80.9B
$64.6M 0.29%
390,034
+51,875
+15% +$8.2M
BAC icon
91
Bank of America
BAC
$435B
$64.5M 0.29%
1,830,321
-285,626
-13% -$9.23M
COR icon
92
Cencora
COR
$60.3B
$64.3M 0.29%
756,817
-419,550
-36% -$36M
NTAP icon
93
NetApp
NTAP
$32.9B
$63.3M 0.29%
1,016,299
-9,217
-0.9% -$538K
AFL icon
94
Aflac
AFL
$63.9B
$62.4M 0.28%
1,179,111
-45,109
-4% -$2.39M
C icon
95
Citigroup
C
$222B
$60.8M 0.28%
761,289
+519
+0.1% +$38.3K
NTRS icon
96
Northern Trust
NTRS
$22.2B
$60.7M 0.28%
571,493
+46,838
+9% +$4.79M
BRK.B icon
97
Berkshire Hathaway Class B
BRK.B
$1.07T
$60.7M 0.28%
267,837
+694
+0.3% +$151K
KLAC icon
98
KLA
KLAC
$275B
$60.4M 0.28%
3,389,080
-1,140
-0% -$19.1K
DIS icon
99
Walt Disney
DIS
$165B
$59.6M 0.27%
412,369
-389
-0.1% -$54.3K
CBRE icon
100
CBRE Group
CBRE
$40.8B
$57.9M 0.26%
944,502
-155,483
-14% -$8.61M

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.